The expression of NR2F6 is significantly up-regulated in a variety of malignant tumors, such as acute myeloid leukemia (AML) (15), breast cancer (16), Head and neck squamous cell carcinoma (17), colon cancer (18), and lymphoma (19). The gene discussed is NR2F6; the disease is cancer.